BACKGROUND: Osteoporosis is the most common metabolic bone disorder of the elderly, affecting the normal bone turnover with an increased bone resorption and subsequent higher risk of fragility fractures. Collagen type 1 is the most represented protein in bone matrix. A genetic variation (Sp1) in intron 1 of COL1A1 gene has been associated to modulation of expression of the alpha 1 chain of collagen type 1 and it is considered a candidate polymorphism for predisposition to osteoporosis status and fragility fractures. Association studies, in ethnically different populations, are needed to strongly confirm the role of this polymorphism in bone metabolism. MATERIALS AND METHODS: We enrolled over 2,000 Italian individuals and studied their bone mineral density (BMD) and fractures in relation to age, sex and body mass index (BMI). Moreover, we analyzed the distribution of Sp1 polymorphism in these individuals and associated it to normal bone status, osteopenic condition or osteoporosis diagnosis, BMD and the presence of low-trauma fractures. RESULTS: The most rare ss genotype showed a trend for osteoporosis diagnosis with respect to both normal and osteopenic status. The same genotype resulted to be associated to lower values of BMD both at spine and femur sites. No association was found with fractures. DISCUSSION: In conclusion the presence of the homozygote ss genotype seemed to predispose to osteoporosis diagnosis and to be more frequent in subjects with lower spine and femur BMD values.
BACKGROUND:Osteoporosis is the most common metabolic bone disorder of the elderly, affecting the normal bone turnover with an increased bone resorption and subsequent higher risk of fragility fractures. Collagen type 1 is the most represented protein in bone matrix. A genetic variation (Sp1) in intron 1 of COL1A1 gene has been associated to modulation of expression of the alpha 1 chain of collagen type 1 and it is considered a candidate polymorphism for predisposition to osteoporosis status and fragility fractures. Association studies, in ethnically different populations, are needed to strongly confirm the role of this polymorphism in bone metabolism. MATERIALS AND METHODS: We enrolled over 2,000 Italian individuals and studied their bone mineral density (BMD) and fractures in relation to age, sex and body mass index (BMI). Moreover, we analyzed the distribution of Sp1 polymorphism in these individuals and associated it to normal bone status, osteopenic condition or osteoporosis diagnosis, BMD and the presence of low-trauma fractures. RESULTS: The most rare ss genotype showed a trend for osteoporosis diagnosis with respect to both normal and osteopenic status. The same genotype resulted to be associated to lower values of BMD both at spine and femur sites. No association was found with fractures. DISCUSSION: In conclusion the presence of the homozygote ss genotype seemed to predispose to osteoporosis diagnosis and to be more frequent in subjects with lower spine and femur BMD values.
Entities:
Keywords:
Sp1 polymorphism; bone mineral density; collagen type 1; fragility fracture risk; osteoporosis; osteoporosis prevention
Authors: L Alvarez; J Oriola; J Jo; T Ferró; F Pons; P Peris; N Guañabens; M Durán; A Monegal; M J Martínez de Osaba; F Rivera-Fillat; A M Ballesta Journal: Clin Chem Date: 1999-06 Impact factor: 8.327
Authors: C De Laet; J A Kanis; A Odén; H Johanson; O Johnell; P Delmas; J A Eisman; H Kroger; S Fujiwara; P Garnero; E V McCloskey; D Mellstrom; L J Melton; P J Meunier; H A P Pols; J Reeve; A Silman; A Tenenhouse Journal: Osteoporos Int Date: 2005-06-01 Impact factor: 4.507
Authors: V Braga; M Mottes; S Mirandola; V Lisi; G Malerba; L Sartori; G Bianchi; D Gatti; M Rossini; D Bianchini; S Adami Journal: Calcif Tissue Int Date: 2000-11 Impact factor: 4.333
Authors: A G Uitterlinden; H Burger; Q Huang; F Yue; F E McGuigan; S F Grant; A Hofman; J P van Leeuwen; H A Pols; S H Ralston Journal: N Engl J Med Date: 1998-04-09 Impact factor: 91.245
Authors: V Mann; E E Hobson; B Li; T L Stewart; S F Grant; S P Robins; R M Aspden; S H Ralston Journal: J Clin Invest Date: 2001-04 Impact factor: 14.808
Authors: Stuart H Ralston; André G Uitterlinden; Maria Luisa Brandi; Susana Balcells; Bente L Langdahl; Paul Lips; Roman Lorenc; Barbara Obermayer-Pietsch; Serena Scollen; Mariona Bustamante; Lise Bjerre Husted; Alisoun H Carey; Adolfo Diez-Perez; Alison M Dunning; Alberto Falchetti; Elzbieta Karczmarewicz; Marcin Kruk; Johannes P T M van Leeuwen; Joyce B J van Meurs; Jon Mangion; Fiona E A McGuigan; Leonardo Mellibovsky; Francesca del Monte; Huibert A P Pols; Jonathan Reeve; David M Reid; Wilfried Renner; Fernando Rivadeneira; Natasja M van Schoor; Rachael E Sherlock; John P A Ioannidis Journal: PLoS Med Date: 2006-02-21 Impact factor: 11.069